Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACRV | NSRX | MGX | ||
| Company | Acrivon Therapeutics Inc | Nasus Pharma Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 1.9400 | 7.11 | 1.6800 | ||
| High | 2.0400 | 7.20 | 1.7200 | ||
| Low | 1.9000 | 6.99 | 1.6500 | ||
| Latest | 1.9800 | 7.05 | 1.6600 | ||
| Change | +0.1100 | -0.05 | -0.0300 | ||
| % Change | +5.88% | -0.70% | -1.78% | ||
| Volume | 2,022,600 | 4,200 | 200,100 | ||
| 20-Day Average Volume | 3,389,000 | 9,340 | 314,420 | ||
| Previous Close | 1.8700 | 7.10 | 1.6900 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.2250 | 7.34 | 1.7105 | ||
| 20-Day Raw Stochastic | 20.60% | 28.99% | 27.59% | ||
| 20-Day Relative Strength | 45.93 | 47.97 | 43.71 | ||
| Weighted Alpha | -0.11 | N/A | -40.83 | ||
| Today's Opinion | 24% Buy | N/A | 88% Sell | ||
| Previous Opinion | 24% Buy | N/A | 88% Sell | ||
| Last Month's Opinion | 88% Buy | N/A | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.14% since 01/09/26 | -0.70% since 01/09/26 | -7.26% since 01/09/26 | ||
| Low | 1.5700 on 01/13/26 | 6.99 on 01/16/26 | 1.6500 on 01/16/26 | ||
| High | 2.0400 on 01/16/26 | 7.70 on 01/14/26 | 1.7929 on 01/12/26 | ||
| 1-Month | |||||
| %Chg | -18.18% since 12/16/25 | +3.68% since 12/12/25 | -2.92% since 12/16/25 | ||
| Low | 1.5700 on 01/13/26 | 6.05 on 12/19/25 | 1.5800 on 12/31/25 | ||
| High | 3.5600 on 01/07/26 | 9.50 on 12/31/25 | 1.8700 on 12/22/25 | ||
| 3-Month | |||||
| %Chg | +5.88% since 10/16/25 | -10.98% since 10/16/25 | -50.15% since 10/16/25 | ||
| Low | 1.5700 on 01/13/26 | 6.05 on 12/19/25 | 1.4700 on 11/21/25 | ||
| High | 3.5600 on 01/07/26 | 9.50 on 12/31/25 | 3.3950 on 10/20/25 | ||
| 6-Month | |||||
| %Chg | +52.31% since 07/16/25 | N/A since 08/13/25 | -20.95% since 07/16/25 | ||
| Low | 1.2002 on 08/11/25 | 5.90 on 10/01/25 | 1.4700 on 11/21/25 | ||
| High | 3.5600 on 01/07/26 | 9.99 on 08/22/25 | 3.9500 on 10/16/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 62,479 | 63,870 | 62,328 | ||
| Shares Outstanding, K | 31,555 | 9,060 | 37,547 | ||
| Annual Sales | 0 | 0 | 52,300,000 | ||
| Annual Net Income | -80,560,000 | -1,532,000 | -78,060,000 | ||
| Last Quarter Sales | 0 | N/A | 8,660,000 | ||
| Last Quarter Net Income | -18,230,000 | N/A | -20,390,000 | ||
| 60-Month Beta | 1.73 | N/A | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 11/13/25 | N/A | -0.55 on 11/11/25 | ||
| Latest Earnings Date | 03/26/26 | N/A | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||